{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T14:42:32Z","timestamp":1794580952226,"version":"4.9.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T00:00:00Z","timestamp":1686268800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T00:00:00Z","timestamp":1686268800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiol med"],"DOI":"10.1007\/s11547-023-01659-w","type":"journal-article","created":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T12:01:57Z","timestamp":1686312117000},"page":"877-885","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Stereotactic boost on residual disease after external-beam irradiation in clinical stage III non-small cell lung cancer: mature results of stereotactic body radiation therapy post radiation therapy (SBRTpostRT) study"],"prefix":"10.1007","volume":"128","author":[{"given":"Silvana","family":"Parisi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Ferini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7300-1168","authenticated-orcid":false,"given":"Sara","family":"Lillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Brogna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Chillari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Ferrantelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Settineri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Santacaterina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Platania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Leotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Casablanca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Pontoriero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Adamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Minutoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Bottari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Cacciola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Pergolizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,9]]},"reference":[{"key":"1659_CR1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3747\/co.26.4096","volume":"26","author":"PK Cheema","year":"2019","unstructured":"Cheema PK, Rothenstein J, Melosky B et al (2019) Perspectives on treatment advances for stage iii locally advanced unresectable non-small-cell lung cancer. Curr Oncol 26:37\u201342. https:\/\/doi.org\/10.3747\/co.26.4096","journal-title":"Curr Oncol"},{"key":"1659_CR2","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S1470-2045(14)71207-0","volume":"16","author":"JD Bradley","year":"2015","unstructured":"Bradley JD, Paulus R, Komaki R et al (2015) Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial p. Lancet Oncol 16:187\u2013199. https:\/\/doi.org\/10.1016\/S1470-2045(14)71207-0","journal-title":"Lancet Oncol"},{"key":"1659_CR3","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1056\/nejmoa1709937","volume":"377","author":"SJ Antonia","year":"2017","unstructured":"Antonia SJ, Villegas A, Daniel D et al (2017) Durvalumab after Chemoradiotherapy in stage III Non\u2013small-cell lung cancer. N Engl J Med 377:1919\u20131929. https:\/\/doi.org\/10.1056\/nejmoa1709937","journal-title":"N Engl J Med"},{"key":"1659_CR4","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.jtho.2020.12.015","volume":"16","author":"C Faivre-Finn","year":"2021","unstructured":"Faivre-Finn C, Vicente D, Kurata T et al (2021) Four-year survival with Durvalumab after Chemoradiotherapy in stage III NSCLC\u2014an update from the Pacific trial. J Thorac Oncol 16:860\u2013867. https:\/\/doi.org\/10.1016\/j.jtho.2020.12.015","journal-title":"J Thorac Oncol"},{"key":"1659_CR5","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1002\/1097-0142(19800601)45:11<2744::AID-CNCR2820451108>3.0.CO;2-U","volume":"45","author":"CA Perez","year":"1980","unstructured":"Perez CA, Stanley K, Rubin P et al (1980) A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung. Preliminary report by the radiation therapy oncology group. Cancer 45:2744\u20132753. https:\/\/doi.org\/10.1002\/1097-0142(19800601)45:11%3c2744::AID-CNCR2820451108%3e3.0.CO;2-U","journal-title":"Cancer"},{"key":"1659_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/annonc\/mdx222","volume":"28","author":"PE Postmus","year":"2017","unstructured":"Postmus PE, Kerr KM, Oudkerk M et al (2017) Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 28:21. https:\/\/doi.org\/10.1093\/annonc\/mdx222","journal-title":"Ann Oncol"},{"key":"1659_CR7","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1200\/JCO.2009.26.2543","volume":"28","author":"A Aup\u00e9rin","year":"2010","unstructured":"Aup\u00e9rin A, Le P\u00e9choux C, Rolland E et al (2010) Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced Non-small-cell lung cancer. J Clin Oncol 28:2181\u20132190. https:\/\/doi.org\/10.1200\/JCO.2009.26.2543","journal-title":"J Clin Oncol"},{"key":"1659_CR8","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ijrobp.2010.09.004","volume":"82","author":"M MacHtay","year":"2012","unstructured":"MacHtay M, Bae K, Movsas B et al (2012) Higher biologically effective dose of radiotherapy is associated with improved outcomes for locally advanced non-small cell lung carcinoma treated with chemoradiation: An analysis of the radiation therapy oncology group. Int J Radiat Oncol Biol Phys 82:425\u2013434. https:\/\/doi.org\/10.1016\/j.ijrobp.2010.09.004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1659_CR9","doi-asserted-by":"publisher","first-page":"S2522","DOI":"10.21037\/jtd.2017.12.50","volume":"10","author":"MAL Vyfhuis","year":"2018","unstructured":"Vyfhuis MAL, Rice S, Remick J et al (2018) Reirradiation for locoregionally recurrent non-small cell lung cancer. J Thorac Dis 10:S2522\u2013S2536. https:\/\/doi.org\/10.21037\/jtd.2017.12.50","journal-title":"J Thorac Dis"},{"key":"1659_CR10","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.ijrobp.2019.08.034","volume":"105","author":"D Raben","year":"2019","unstructured":"Raben D, Rimner A, Senan S et al (2019) Patterns of disease progression with Durvalumab in stage III Non-small cell lung cancer (PACIFIC). Int J Radiat Oncol 105:683. https:\/\/doi.org\/10.1016\/j.ijrobp.2019.08.034","journal-title":"Int J Radiat Oncol"},{"key":"1659_CR11","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ijrobp.2021.04.014","volume":"111","author":"Y Tateishi","year":"2021","unstructured":"Tateishi Y, Takeda A, Horita N et al (2021) Stereotactic body radiation therapy with a high maximum dose improves local control, cancer-specific death, and overall survival in peripheral early-stage Non-small cell lung cancer. Int J Radiat Oncol Biol Phys 111:143\u2013151. https:\/\/doi.org\/10.1016\/j.ijrobp.2021.04.014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1659_CR12","doi-asserted-by":"publisher","first-page":"529","DOI":"10.21037\/tlcr-2020-nsclc-04","volume":"10","author":"OL Alcibar","year":"2021","unstructured":"Alcibar OL, Nadal E, Palomar IR, Navarro-Martin A (2021) Systematic review of stereotactic body radiotherapy in stage III non-small cell lung cancer. Transl Lung Cancer Res 10:529\u2013538. https:\/\/doi.org\/10.21037\/tlcr-2020-nsclc-04","journal-title":"Transl Lung Cancer Res"},{"key":"1659_CR13","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1007\/s12094-016-1552-7","volume":"18","author":"RE Vadal\u00e0","year":"2016","unstructured":"Vadal\u00e0 RE, Santacaterina A, Sindoni A et al (2016) Stereotactic body radiotherapy in non-operable lung cancer patients. Clin Transl Oncol 18:1158\u20131159. https:\/\/doi.org\/10.1007\/s12094-016-1552-7","journal-title":"Clin Transl Oncol"},{"key":"1659_CR14","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/j.ijrobp.2010.07.1977","volume":"81","author":"FM Kong","year":"2011","unstructured":"Kong FM, Ritter T, Quint DJ et al (2011) Consideration of dose limits for organs at risk of thoracic radiotherapy: atlas for lung, proximal bronchial tree, Esophagus, spinal cord, ribs, and brachial plexus. Int J Radiat Oncol 81:1442\u20131457. https:\/\/doi.org\/10.1016\/j.ijrobp.2010.07.1977","journal-title":"Int J Radiat Oncol"},{"key":"1659_CR15","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228\u2013247. https:\/\/doi.org\/10.1016\/j.ejca.2008.10.026","journal-title":"Eur J Cancer"},{"key":"1659_CR16","doi-asserted-by":"publisher","first-page":"122","DOI":"10.2967\/jnumed.108.057307","volume":"50","author":"RL Wahl","year":"2009","unstructured":"Wahl RL, Jacene H, Kasamon Y, Lodge MA (2009) From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med 50:122\u2013150. https:\/\/doi.org\/10.2967\/jnumed.108.057307","journal-title":"J Nucl Med"},{"key":"1659_CR17","unstructured":"Ponce MC, Sharma S (2022) Pulmonary Function Tests"},{"key":"1659_CR18","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1700\/1053.11502","volume":"98","author":"S Ramella","year":"2012","unstructured":"Ramella S, Maranzano E, Frata P et al (2012) Radiotherapy in Italy for non-small cell lung cancer: patterns of care survey. Tumori 98:66\u201378. https:\/\/doi.org\/10.1700\/1053.11502","journal-title":"Tumori"},{"key":"1659_CR19","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/j.annonc.2021.08.1994","volume":"32","author":"J Remon","year":"2021","unstructured":"Remon J, Soria JC, Peters S (2021) Early and locally advanced non-small-cell lung cancer: an update of the ESMO Clinical practice guidelines focusing on diagnosis, staging, systemic and local therapy. Ann Oncol 32:1637\u20131642. https:\/\/doi.org\/10.1016\/j.annonc.2021.08.1994","journal-title":"Ann Oncol"},{"key":"1659_CR20","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.ijrobp.2012.11.011","volume":"85","author":"J Feddock","year":"2013","unstructured":"Feddock J, Arnold SM, Shelton BJ et al (2013) Stereotactic body radiation therapy can be used safely to boost residual disease in locally advanced non-small cell lung cancer: a prospective study. Int J Radiat Oncol Biol Phys 85:1325\u20131331. https:\/\/doi.org\/10.1016\/j.ijrobp.2012.11.011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1659_CR21","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/j.jtho.2017.07.036","volume":"12","author":"KA Higgins","year":"2017","unstructured":"Higgins KA, Pillai RN, Chen Z et al (2017) Concomitant chemotherapy and radiotherapy with SBRT boost for Unresectable stage III Non-small cell lung cancer: a phase I study. J Thorac Oncol 12:1687\u20131695. https:\/\/doi.org\/10.1016\/j.jtho.2017.07.036","journal-title":"J Thorac Oncol"},{"key":"1659_CR22","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.ijrobp.2016.08.032","volume":"96","author":"JT Hepel","year":"2016","unstructured":"Hepel JT, Leonard KL, Safran H et al (2016) Stereotactic body radiation therapy boost after concurrent Chemoradiation for locally advanced non-small cell lung cancer: a phase 1 dose escalation study. Int J Radiat Oncol Biol Phys 96:1021\u20131027. https:\/\/doi.org\/10.1016\/j.ijrobp.2016.08.032","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1659_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1748-717X-8-179","volume":"8","author":"SD Karam","year":"2013","unstructured":"Karam SD, Horne ZD, Hong RL et al (2013) Dose escalation with stereotactic body radiation therapy boost for locally advanced non small cell lung cancer. Radiat Oncol 8:1\u20138. https:\/\/doi.org\/10.1186\/1748-717X-8-179","journal-title":"Radiat Oncol"},{"key":"1659_CR24","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.radonc.2018.03.024","volume":"127","author":"J Doyen","year":"2018","unstructured":"Doyen J, Poudenx M, Gal J et al (2018) Stereotactic ablative radiotherapy after concomitant chemoradiotherapy in non-small cell lung cancer: a TITE-CRM phase 1 trial. Radiother Oncol 127:239\u2013245. https:\/\/doi.org\/10.1016\/j.radonc.2018.03.024","journal-title":"Radiother Oncol"},{"key":"1659_CR25","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.ijrobp.2017.07.036","volume":"99","author":"S Kumar","year":"2017","unstructured":"Kumar S, Feddock J, Li X et al (2017) Update of a prospective study of stereotactic body radiation therapy for post-chemoradiation residual disease in stage II\/III Non-small cell lung cancer. Int J Radiat Oncol 99:652\u2013659. https:\/\/doi.org\/10.1016\/j.ijrobp.2017.07.036","journal-title":"Int J Radiat Oncol"},{"key":"1659_CR26","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.lungcan.2016.03.019","volume":"96","author":"A Sindoni","year":"2016","unstructured":"Sindoni A, Minutoli F, Pontoriero A et al (2016) Usefulness of four dimensional (4D) PET\/CT imaging in the evaluation of thoracic lesions and in radiotherapy planning: review of the literature. Lung Cancer 96:78\u201386. https:\/\/doi.org\/10.1016\/j.lungcan.2016.03.019","journal-title":"Lung Cancer"},{"key":"1659_CR27","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1148\/radiol.2016160913","volume":"281","author":"A Sindoni","year":"2016","unstructured":"Sindoni A, Minutoli F, Baldari S, Pergolizzi S (2016) Importance of respiratory-gated PET\/CT in thoracic Tumors. Radiology 281:321\u2013323. https:\/\/doi.org\/10.1148\/radiol.2016160913","journal-title":"Radiology"},{"key":"1659_CR28","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.phro.2018.08.003","volume":"7","author":"TWH Meijer","year":"2018","unstructured":"Meijer TWH, Wijsman R, Usmanij EA et al (2018) Stereotactic radiotherapy boost after definite chemoradiation for non-responding locally advanced NSCLC based on early response monitoring 18F-FDG-PET\/CT. Phys Imaging Radiat Oncol 7:16\u201322. https:\/\/doi.org\/10.1016\/j.phro.2018.08.003","journal-title":"Phys Imaging Radiat Oncol"},{"key":"1659_CR29","doi-asserted-by":"publisher","first-page":"5939","DOI":"10.1038\/s41598-021-85131-7","volume":"11","author":"M Or","year":"2021","unstructured":"Or M, Liu B, Lam J et al (2021) A systematic review and meta-analysis of treatment-related toxicities of curative and palliative radiation therapy in non-small cell lung cancer. Sci Rep 11:5939. https:\/\/doi.org\/10.1038\/s41598-021-85131-7","journal-title":"Sci Rep"},{"key":"1659_CR30","doi-asserted-by":"publisher","first-page":"409","DOI":"10.4236\/jct.2021.127036","volume":"12","author":"JD Anderson","year":"2021","unstructured":"Anderson JD, Hu J, Li J et al (2021) Impact of cardiac dose on overall survival in lung stereotactic body radiotherapy (SBRT) compared to conventionally fractionated radiotherapy for locally advanced Non-small cell lung cancer (LA-NSCLC). J Cancer Ther 12:409\u2013423. https:\/\/doi.org\/10.4236\/jct.2021.127036","journal-title":"J Cancer Ther"},{"key":"1659_CR31","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.radonc.2018.06.039","volume":"130","author":"F Lucia","year":"2019","unstructured":"Lucia F, Key S, Dissaux G et al (2019) Inhomogeneous tumor dose distribution provides better local control than homogeneous distribution in stereotactic radiotherapy for brain metastases. Radiother Oncol 130:132\u2013138. https:\/\/doi.org\/10.1016\/j.radonc.2018.06.039","journal-title":"Radiother Oncol"},{"key":"1659_CR32","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.rpor.2020.02.010","volume":"25","author":"A Cacciola","year":"2020","unstructured":"Cacciola A, Parisi S, Tamburella C et al (2020) Stereotactic body radiation therapy and radiofrequency ablation for the treatment of liver metastases: How and when? Reports Pract Oncol Radiother 25:299\u2013306. https:\/\/doi.org\/10.1016\/j.rpor.2020.02.010","journal-title":"Reports Pract Oncol Radiother"},{"key":"1659_CR33","doi-asserted-by":"crossref","unstructured":"Joiner M, Kogel A van der (2009) Basic clinical radiobiology, 4th ed. Hodder Harnold, London (UK)","DOI":"10.1201\/b15450"},{"key":"1659_CR34","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1177\/10781552211027348","volume":"28","author":"S Parisi","year":"2022","unstructured":"Parisi S, Napoli I, Lillo S et al (2022) Spine eburnation in a metastatic lung cancer patient treated with immunotherapy and radiotherapy. The first case report of bystander effect on bone. J Oncol Pharm Pract 28:237\u2013241. https:\/\/doi.org\/10.1177\/10781552211027348","journal-title":"J Oncol Pharm Pract"},{"key":"1659_CR35","doi-asserted-by":"publisher","first-page":"3290","DOI":"10.3390\/cancers13133290","volume":"13","author":"G Ferini","year":"2021","unstructured":"Ferini G, Valenti V, Tripoli A et al (2021) Lattice or oxygen-guided radiotherapy: what If they converge? Possible future directions in the era of immunotherapy. Cancers Basel 13:3290. https:\/\/doi.org\/10.3390\/cancers13133290","journal-title":"Cancers Basel"},{"key":"1659_CR36","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.3390\/cancers14163909","volume":"14","author":"G Ferini","year":"2022","unstructured":"Ferini G, Parisi S, Lillo S et al (2022) Impressive results after metabolism-guided lattice irradiation in patients submitted to palliative radiation therapy: preliminary results of LATTICE_01 multicenter study. Cancers Basel 14:3909. https:\/\/doi.org\/10.3390\/cancers14163909","journal-title":"Cancers Basel"}],"container-title":["La radiologia medica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-023-01659-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11547-023-01659-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-023-01659-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T10:18:31Z","timestamp":1688379511000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11547-023-01659-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,9]]},"references-count":36,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["1659"],"URL":"https:\/\/doi.org\/10.1007\/s11547-023-01659-w","relation":{},"ISSN":["1826-6983"],"issn-type":[{"value":"1826-6983","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,9]]},"assertion":[{"value":"12 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the ethics committee of University of Messina with protocol number 0003722.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all patients included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Informed consent regarding publishing their data was obtained from all patients included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}